TSHA – taysha gene therapies, inc. (US:NASDAQ)
Stock Stats
News
Drugmakers tumble on reports FDA's top vaccine regulator set to leave [Yahoo! Finance]
Biotech stocks tumble on reports FDA's top vaccine regulator to leave [Yahoo! Finance]
Biotech stocks tumble on reports FDA's top vaccine regulator to leave [Yahoo! Finance Canada]
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
Form 4 Taysha Gene Therapies, For: Mar 11 Filed by: Alam Kamran
Form 10-K Taysha Gene Therapies, For: Dec 31
Form 8-K Taysha Gene Therapies, For: Feb 26
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RTW INVESTMENTS, LP
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: FMR LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.